Cargando…

Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices

Background and study aims: Patients with a continuous-flow left ventricular assist device (LVAD) have a 65 % incidence of bleeding events within the first year. The majority of gastrointestinal bleeding (GIB) is from gastrointestinal angiodyplasia (GIAD). The primary aim of the study was to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Cochrane, Justin, Jackson, Christian, Schlepp, Greg, Strong, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798933/
https://www.ncbi.nlm.nih.gov/pubmed/27004257
http://dx.doi.org/10.1055/s-0042-101752
_version_ 1782422239347474432
author Cochrane, Justin
Jackson, Christian
Schlepp, Greg
Strong, Richard
author_facet Cochrane, Justin
Jackson, Christian
Schlepp, Greg
Strong, Richard
author_sort Cochrane, Justin
collection PubMed
description Background and study aims: Patients with a continuous-flow left ventricular assist device (LVAD) have a 65 % incidence of bleeding events within the first year. The majority of gastrointestinal bleeding (GIB) is from gastrointestinal angiodyplasia (GIAD). The primary aim of the study was to determine whether GIAD was associated with a higher rate of significant bleeding, an increased number of bleeding events per year, and a higher rate of transfusion compared to non-GIAD sources. Patients and methods: This retrospective cohort study included 118 individuals who received a LVAD at a tertiary medical center from 2006 through 2014. Patients were subdivided into GIB and non-GIB for comparison of patient demographics, comorbid conditions, and laboratory data. GIB was further divided into sources of GIB, GIAD, obscure, or non-GIAD to establish severity of bleeding, rate of re-bleeding, and transfusion rate. Results: GIAD is associated with an increased number of bleeding events compared to non-GIAD sources of GIB (2.07 vs 1.23, P = 0.01) and a higher number of bleeding events per year (0.806 vs. 0.455 P = 0.001). GIAD compared to non-GIAD sources of GIB was associated with an increased incidence of major bleeding (100 % vs 60 %, P = 0.006) and increased rates of transfusion (8.8 vs 2.95 units, P = 0.0004). Cox Regression analysis between non-GIB and GIAD demonstrated increased risk with age (P = 0.001), history of chronic kidney disease (P = 0.005), and length of stay after LVAD implantation of more than 45 days (P = 0.04). History of hypertension (P = 0.045), diabetes mellitus (P = 0.016), and male gender was associated with decreased risk (P = 0.04). Conclusion: Patients with a continuous-flow LVAD who develop a GIB secondary to GIAD have a higher rate of major bleeding, multiple bleeding events, and require more transfusions to achieve stabilization compared to patients who do not have GIAD.
format Online
Article
Text
id pubmed-4798933
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher © Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-47989332016-03-21 Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices Cochrane, Justin Jackson, Christian Schlepp, Greg Strong, Richard Endosc Int Open Article Background and study aims: Patients with a continuous-flow left ventricular assist device (LVAD) have a 65 % incidence of bleeding events within the first year. The majority of gastrointestinal bleeding (GIB) is from gastrointestinal angiodyplasia (GIAD). The primary aim of the study was to determine whether GIAD was associated with a higher rate of significant bleeding, an increased number of bleeding events per year, and a higher rate of transfusion compared to non-GIAD sources. Patients and methods: This retrospective cohort study included 118 individuals who received a LVAD at a tertiary medical center from 2006 through 2014. Patients were subdivided into GIB and non-GIB for comparison of patient demographics, comorbid conditions, and laboratory data. GIB was further divided into sources of GIB, GIAD, obscure, or non-GIAD to establish severity of bleeding, rate of re-bleeding, and transfusion rate. Results: GIAD is associated with an increased number of bleeding events compared to non-GIAD sources of GIB (2.07 vs 1.23, P = 0.01) and a higher number of bleeding events per year (0.806 vs. 0.455 P = 0.001). GIAD compared to non-GIAD sources of GIB was associated with an increased incidence of major bleeding (100 % vs 60 %, P = 0.006) and increased rates of transfusion (8.8 vs 2.95 units, P = 0.0004). Cox Regression analysis between non-GIB and GIAD demonstrated increased risk with age (P = 0.001), history of chronic kidney disease (P = 0.005), and length of stay after LVAD implantation of more than 45 days (P = 0.04). History of hypertension (P = 0.045), diabetes mellitus (P = 0.016), and male gender was associated with decreased risk (P = 0.04). Conclusion: Patients with a continuous-flow LVAD who develop a GIB secondary to GIAD have a higher rate of major bleeding, multiple bleeding events, and require more transfusions to achieve stabilization compared to patients who do not have GIAD. © Georg Thieme Verlag KG 2016-03 /pmc/articles/PMC4798933/ /pubmed/27004257 http://dx.doi.org/10.1055/s-0042-101752 Text en © Thieme Medical Publishers
spellingShingle Article
Cochrane, Justin
Jackson, Christian
Schlepp, Greg
Strong, Richard
Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices
title Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices
title_full Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices
title_fullStr Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices
title_full_unstemmed Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices
title_short Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices
title_sort gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798933/
https://www.ncbi.nlm.nih.gov/pubmed/27004257
http://dx.doi.org/10.1055/s-0042-101752
work_keys_str_mv AT cochranejustin gastrointestinalangiodysplasiaisassociatedwithsignificantgastrointestinalbleedinginpatientswithcontinuousleftventricularassistdevices
AT jacksonchristian gastrointestinalangiodysplasiaisassociatedwithsignificantgastrointestinalbleedinginpatientswithcontinuousleftventricularassistdevices
AT schleppgreg gastrointestinalangiodysplasiaisassociatedwithsignificantgastrointestinalbleedinginpatientswithcontinuousleftventricularassistdevices
AT strongrichard gastrointestinalangiodysplasiaisassociatedwithsignificantgastrointestinalbleedinginpatientswithcontinuousleftventricularassistdevices